US 12161696
Methods of treating hemophilic arthropathy using chimeric clotting factors
granted A61KA61K38/37A61K38/4846
Quick answer
US patent 12161696 (Methods of treating hemophilic arthropathy using chimeric clotting factors) held by BIOVERATIV THERAPEUTICS INC. expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/37, A61K38/4846, A61P, A61P19/02